Immunocore IMCR Crushes Q1 2026 Estimates EPS 025 Tops Views XPeng Inc XPEV Reports Strong Q4 2025 Revenue NA EPS Beats Cue Biopharma CUE Jumps 233 on Strong Momentum 20260520 Texas TPL Q1 2026 Beat Revenue NA EPS Exceeds by Significant Standard Chartered to Cut Nearly 8000 Jobs in AIDriven Restructuring